Alpha 1 Biomedicals, SciClone news

SCLN (San Mateo, Calif.) has been granted rights to manufacture thymosin alpha 1 for its sales territory in the arbitration of its disupte with ALBM, which had been sole supplier of the drug.

Thomas Moore, chairman and CEO of SCLN, said SCLN is in discussions with four peptide manufacturers and will finalize an agreement within the quarter. He said the company more than likely will choose two manufacturers. ...